At a glance
- What they are
- Injections made from your own blood or cells (like PRP and stem cell shots), bone graft and bone-growth products used in surgery, and biologic medicines for conditions like rheumatoid arthritis.[1]
- Why people consider them
- To avoid or delay surgery, help bones fuse during surgery, or control inflammatory arthritis.
- What the evidence shows
- PRP did no better than placebo in large trials for knee arthritis, Achilles pain and ankle arthritis.[4][5][6] The FDA hasn't approved regenerative medicine therapies for any orthopedic condition.[2]
- What it costs
- Injections like PRP and stem cell treatments are often paid out of pocket, so get a written estimate first.
- What to ask
- What the best trials show compared with placebo, whether the product is FDA-approved for your use, and how biologic medicines will be timed around surgery.
The short version
- In a large placebo-controlled trial, PRP injections did no better than salt-water injections for knee arthritis pain over a year.[4] Trials in Achilles tendon pain and ankle arthritis found the same.[5][6]
- The FDA says regenerative medicine products such as stem cells, fat-derived cells, cord blood, amniotic fluid and exosomes have not been approved for any orthopedic condition, and it has received reports of blindness, tumors and infections from unapproved products.[2]
- Lubricating injections (hyaluronic acid) reduced knee arthritis pain by less than a meaningful amount and were linked to more serious side effects than placebo in a large review.[8]
- In spine fusion, the bone-growth protein BMP-2 helped bones fuse more often but didn't meaningfully reduce pain, and caused more early pain and other harms.[11][12]
- If you take a biologic medicine for arthritis, your rheumatologist and surgeon should plan its timing around surgery together.[16]
What "biologics" means
The FDA uses "biological products" for a wide range of products made from living sources: blood and blood components, cells, tissues, vaccines and proteins made with biotechnology.[1] In everyday orthopedic and spine care, the word shows up in three places:
- Injections made from your own body, such as platelet-rich plasma (PRP), bone marrow concentrate and fat-derived cells, often marketed as "regenerative" or "stem cell" treatments.[2]
- Bone graft and bone-growth products used during fusion and fracture surgery.
- Biologic medicines, such as TNF inhibitors, used for rheumatoid arthritis and related conditions. Lower-cost copies called biosimilars have no clinically meaningful differences from the original.[17]
Platelet-rich plasma (PRP)
PRP is made by spinning a sample of your blood to concentrate the platelets, which carry growth factors, and injecting it into a joint or tendon. Preparation methods vary widely, which makes studies hard to compare.[3]
The research in detail: What the trials found
- Knee arthritis: in the RESTORE trial of 288 people, three PRP injections were no better than placebo injections for pain or cartilage after 12 months.[4] A 2026 pooled analysis did find benefits compared with placebo, and its authors called for standardized methods and larger trials.[18]
- Achilles tendon pain: in a trial of 240 people, PRP was no better than a sham injection at six months.[5]
- Ankle arthritis: PRP was no better than placebo injections in a randomized trial.[6]
- Soft tissue injuries in general: a Cochrane review found insufficient evidence to support PRP for ligament, muscle and tendon injuries, including when added during rotator cuff surgery.[3]
- Tennis elbow: a network meta-analysis suggested PRP can improve pain compared with steroid injections, with few complications.[7]
PRP is made from your own blood, and serious side effects were uncommon in trials, though injection-site discomfort was common.[5] The bigger issue is cost, since it's usually paid out of pocket.
"Stem cell" and regenerative injections
Clinics across the US market injections of fat-derived cells, bone marrow concentrate, umbilical cord blood, amniotic fluid, Wharton's jelly and exosomes for arthritis, back pain and sports injuries, often claiming they comply with federal rules.[2][10]
The FDA says these products need FDA approval before they can be marketed, and that regenerative medicine therapies have not been approved to treat any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain or hip pain. It has received reports of blindness, tumor formation and infections from unapproved products.[2]
The research is still early. In a trial where people with arthritis in both knees had bone marrow concentrate in one knee and salt water in the other, pain improved a lot, but equally in both knees.[9] A 2026 review of 28 trials concluded that cell-based injections mostly affect symptoms rather than rebuilding cartilage, with more local reactions.[19]
If you're offered a "stem cell" injection, ask whether it's part of an FDA-regulated clinical trial. If it isn't, it isn't approved for your condition.[2]
Lubricating (hyaluronic acid) injections
Hyaluronic acid, sometimes called viscosupplementation or "gel shots," is a thick fluid injected into the knee. A review of 169 trials with more than 21,000 people found it reduced knee arthritis pain slightly more than placebo, but by less than a difference patients would notice, and it was linked to a higher risk of serious adverse events. The authors said the findings don't support broad use.[8]
Bone graft and BMP in surgery
Fusion surgery joins bones by getting them to grow together. Surgeons add bone graft to help.
- Your own bone (autograft), often taken from the pelvis (iliac crest), is the traditional standard. The tradeoff is a second wound: in one study of spine fusion patients, about 30% had chronic pain where the bone was taken.[14] After neck fusion, about half had difficulty walking for a while after a hip bone harvest.[15]
- Donor bone and bone substitutes avoid a second wound. They include processed donor bone and synthetic materials.
- BMP-2 is a lab-made protein that stimulates bone growth.
The BMP-2 story
Two independent analyses of the original trial data, published in 2013, found that compared with bone from the hip, BMP-2 increased fusion rates but reduced pain by only a clinically insignificant amount, and increased early pain after surgery.[11][12] One found more wound complications and swallowing problems, concluded BMP-2 has no proven clinical advantage over bone graft, and found that early industry-funded publications had underreported harms.[11] A separate review estimated the risk of complications was 10 to 50 times higher than first reported.[13] Cancer risk was raised in one analysis but inconclusive overall.[11][12]
BMP-2 is still used in some complex cases. A 2026 study of high-risk spinal deformity surgery found fewer mechanical failures with BMP-2,[20] and a 2026 cost analysis found it was cost-effective only when the risk of a failed fusion is high.[21] Ask your surgeon whether they plan to use it and why.
Biologic medicines and surgery
Biologic medicines such as TNF inhibitors calm the immune system, which helps rheumatoid arthritis and related diseases but can raise infection risk. The 2022 American College of Rheumatology and hip and knee surgeons' guideline gives specific advice on which antirheumatic medicines to continue, which to pause, and when to restart them around hip and knee replacement.[16]
In a study of 4,288 hip and knee replacements in people taking infliximab, having the last infusion within four weeks of surgery wasn't linked to more serious infections. Steroid (glucocorticoid) use, especially more than 10 mg a day, was.[22]
Don't stop or change a biologic or steroid on your own. Ask your rheumatologist and surgeon to agree on a plan and give it to you in writing.
After an injection or surgery
After a PRP or similar injection, injection-site discomfort is common for a short time.[5] Ask whether to rest the joint, which pain relievers to avoid, and when to restart exercise or therapy, since advice varies.
After fusion surgery with bone taken from your hip, expect soreness at the hip as well as the spine. Some people have pain there for a long time.[14]
If you paused a biologic medicine for surgery, ask when to restart it, and watch for signs of infection, such as fever or a red, warm, draining wound.[16][22]
Risks to know about
- Unapproved regenerative products: the FDA has received reports of blindness, tumors and infections.[2]
- Hyaluronic acid injections: a higher risk of serious adverse events than placebo in a large review.[8]
- BMP-2 in spine fusion: more early pain, and more wound complications and swallowing problems in one analysis.[11][12]
- Bone taken from the hip: long-term pain at the harvest site in about 30% in one study.[14]
- Biologic and steroid medicines around surgery: infection risk, especially with steroid doses above 10 mg a day.[22]
- Money and time: treatments that don't work for your condition still cost money and can delay effective care.
Questions to ask
- What do the best trials show for my condition, compared with a placebo injection?
Why we ask: For knee arthritis, Achilles tendon pain and ankle arthritis, PRP did no better than placebo injections in large trials. Platelet-rich plasma
- Is this product FDA-approved for what you're using it for, or part of a clinical trial?
Why we ask: The FDA says regenerative medicine therapies haven't been approved for any orthopedic condition. Stem cell and regenerative injections
- Exactly what's in the injection, and how is it prepared?
Why we ask: PRP preparation varies widely, and "stem cell" products range from bone marrow to amniotic fluid. What biologics means
- How much will it cost me, and will my insurance pay anything?
Why we ask: These injections are often paid out of pocket. Ask for a written estimate first. Insurance and costs
- How many injections, and how will we know if it worked?
Why we ask: Agreeing on what counts as success before you start protects your time and money. Platelet-rich plasma
- For fusion surgery: what bone graft will you use, and will you use BMP? Why?
Why we ask: BMP-2 increased fusion rates but didn't meaningfully reduce pain and caused more early pain and other harms in independent analyses. Bone graft and BMP
- If bone is taken from my hip, what pain should I expect there?
Why we ask: About 30% of spine fusion patients had chronic pain where bone was taken in one study. Bone graft and BMP
- If I take a biologic medicine: when should I take my last dose before surgery, and when can I restart?
Why we ask: A rheumatology and surgery guideline covers this, and steroid dose seems to matter for infection risk. Biologic medicines and surgery
Print this page or save it to your phone, and write down the answers during your visit.
Understanding your biologic product options
The companies that make the implants and devices used in this surgery, compared side by side with FDA records and sources, plus recent research and FDA news explained for patients.
Insurance and costs
What to expect to pay: a published Medicare reference price for this surgery, how deductibles and coinsurance work, protections against surprise bills, and the costs people forget.
Recovery supplies
We list recovery supplies at every budget, from gel ice wraps to cold therapy machines, with what to look for in each.
- Cold therapy and swelling
- Keeping track of medicines
Sources
- US Food and Drug Administration. What are "biologics"? Questions and answers. https://www.fda.gov/about-fda/center-biologics-evaluation-and-research-cber/what-are-biologics-questions-and-answers
- US Food and Drug Administration. Important patient and consumer information about regenerative medicine therapies. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/important-patient-and-consumer-information-about-regenerative-medicine-therapies
- Moraes VY, et al. Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2014;CD010071. https://doi.org/10.1002/14651858.CD010071.pub3
- Bennell KL, et al. Effect of intra-articular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis: the RESTORE randomized clinical trial. JAMA. 2021;326:2021-30. https://doi.org/10.1001/jama.2021.19415
- Kearney RS, et al. Effect of platelet-rich plasma injection vs sham injection on tendon dysfunction in patients with chronic midportion Achilles tendinopathy: a randomized clinical trial. JAMA. 2021;326:137-44. https://doi.org/10.1001/jama.2021.6986
- Paget LDA, et al. Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial. JAMA. 2021;326:1595-605. https://doi.org/10.1001/jama.2021.16602
- Arirachakaran A, et al. Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: systematic review and network meta-analysis. J Orthop Traumatol. 2016;17:101-12. https://doi.org/10.1007/s10195-015-0376-5
- Pereira TV, et al. Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis. BMJ. 2022;378:e069722. https://doi.org/10.1136/bmj-2022-069722
- Shapiro SA, et al. A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis. Am J Sports Med. 2017;45:82-90. https://doi.org/10.1177/0363546516662455
- Turner L. US stem cell clinics, patient safety, and the FDA. Trends Mol Med. 2015;21:271-3. https://doi.org/10.1016/j.molmed.2015.02.008
- Fu R, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann Intern Med. 2013;158:890-902. https://doi.org/10.7326/0003-4819-158-12-201306180-00006
- Simmonds MC, et al. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data. Ann Intern Med. 2013;158:877-89. https://doi.org/10.7326/0003-4819-158-12-201306180-00005
- Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11:471-91. https://doi.org/10.1016/j.spinee.2011.04.023
- Fernyhough JC, et al. Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion. Spine. 1992;17:1474-80. https://doi.org/10.1097/00007632-199212000-00006
- Silber JS, et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine. 2003;28:134-9. https://doi.org/10.1097/00007632-200301150-00008
- Goodman SM, et al. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care Res. 2022;74:1399-408. https://doi.org/10.1002/acr.24893
- US Food and Drug Administration. Biosimilars basics for patients. https://www.fda.gov/drugs/biosimilars/biosimilars-basics-patients
- Liu HW. Effectiveness of platelet-rich plasma in knee osteoarthritis: a systematic review and meta-analysis. Int J Rheum Dis. 2026;29:e70827. https://doi.org/10.1111/1756-185X.70827
- Awad G, et al. Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Clin Rheumatol. 2026;45:2905-42. https://doi.org/10.1007/s10067-026-08042-w
- Okonkwo DD, et al. Is rhBMP-2 worth the risk? A data-driven look at fusion outcomes and rhBMP-2-related complication burden in high-risk adult spinal deformity patients. Neurosurgery. 2026. https://doi.org/10.1227/neu.0000000000004163
- Martinazzi BJ, et al. Recombinant human bone morphogenetic protein-2 (rhBMP-2) to prevent symptomatic pseudarthrosis in posterolateral lumbar fusion: a break-even cost-effective analysis. Spine. 2026. https://doi.org/10.1097/BRS.0000000000005745
- George MD, et al. Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty. Arthritis Care Res. 2017;69:1845-54. https://doi.org/10.1002/acr.23209
Spot an error? Tell us and we'll check it and fix it.
